JGUA
John G. Ullman & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $738K | Sell |
1,405
-5,025
| -78% | -$2.64M | 0.11% | 108 |
|
|
2025
Q1 | $4.08M | Buy |
6,430
+3,115
| +94% | +$1.98M | 0.63% | 52 |
|
|
2024
Q4 | $2.36M | Buy |
+3,315
| New | +$2.36M | 0.35% | 80 |
|
|
2023
Q1 | – | Sell |
-4,260
| Closed | -$3.07M | – | 181 |
|
|
2022
Q4 | $3.07M | Sell |
4,260
-130
| -3% | -$93.8K | 0.49% | 54 |
|
|
2022
Q3 | $3.02M | Sell |
4,390
-60
| -1% | -$41.3K | 0.53% | 52 |
|
|
2022
Q2 | $2.63M | Buy |
4,450
+3,650
| +456% | +$2.16M | 0.42% | 62 |
|
|
2022
Q1 | $559K | Hold |
800
| – | – | 0.08% | 117 |
|
|
2021
Q4 | $505K | Hold |
800
| – | – | 0.07% | 118 |
|
|
2021
Q3 | $484K | Hold |
800
| – | – | 0.07% | 117 |
|
|
2021
Q2 | $447K | Hold |
800
| – | – | 0.06% | 121 |
|
|
2021
Q1 | $379K | Hold |
800
| – | – | 0.05% | 121 |
|
|
2020
Q4 | $386K | Hold |
800
| – | – | 0.06% | 115 |
|
|
2020
Q3 | $448K | Hold |
800
| – | – | 0.09% | 84 |
|
|
2020
Q2 | $499K | Hold |
800
| – | – | 0.12% | 68 |
|
|
2020
Q1 | $391K | Hold |
800
| – | – | 0.1% | 80 |
|
|
2019
Q4 | $300K | Sell |
800
-25
| -3% | -$9.38K | 0.05% | 122 |
|
|
2019
Q3 | $229K | Sell |
825
-75
| -8% | -$20.8K | 0.04% | 134 |
|
|
2019
Q2 | $282K | Hold |
900
| – | – | 0.05% | 126 |
|
|
2019
Q1 | $370K | Hold |
900
| – | – | 0.07% | 101 |
|
|
2018
Q4 | $336K | Hold |
900
| – | – | 0.07% | 102 |
|
|
2018
Q3 | $364K | Hold |
900
| – | – | 0.07% | 103 |
|
|
2018
Q2 | $310K | Hold |
900
| – | – | 0.06% | 97 |
|
|
2018
Q1 | $310K | Hold |
900
| – | – | 0.06% | 96 |
|
|
2017
Q4 | $338K | Hold |
900
| – | – | 0.07% | 96 |
|
|
2017
Q3 | $402K | Hold |
900
| – | – | 0.08% | 89 |
|
|
2017
Q2 | $442K | Sell |
900
-50
| -5% | -$24.6K | 0.09% | 91 |
|
|
2017
Q1 | $368K | Hold |
950
| – | – | 0.08% | 98 |
|
|
2016
Q4 | $349K | Buy |
950
+50
| +6% | +$18.4K | 0.07% | 103 |
|
|
2016
Q3 | $362K | Sell |
900
-100
| -10% | -$40.2K | 0.07% | 100 |
|
|
2016
Q2 | $349K | Hold |
1,000
| – | – | 0.07% | 101 |
|
|
2016
Q1 | $360K | Sell |
1,000
-41
| -4% | -$14.8K | 0.08% | 90 |
|
|
2015
Q4 | $565K | Sell |
1,041
-10
| -1% | -$5.43K | 0.12% | 95 |
|
|
2015
Q3 | $489K | Sell |
1,051
-110
| -9% | -$51.2K | 0.12% | 95 |
|
|
2015
Q2 | $592K | Sell |
1,161
-90
| -7% | -$45.9K | 0.11% | 110 |
|
|
2015
Q1 | $565K | Hold |
1,251
| – | – | 0.11% | 109 |
|
|
2014
Q4 | $513K | Sell |
1,251
-14
| -1% | -$5.74K | 0.1% | 116 |
|
|
2014
Q3 | $456K | Hold |
1,265
| – | – | 0.09% | 122 |
|
|
2014
Q2 | $357K | Hold |
1,265
| – | – | 0.07% | 129 |
|
|
2014
Q1 | $380K | Sell |
1,265
-100
| -7% | -$30K | 0.07% | 124 |
|
|
2013
Q4 | $376K | Sell |
1,365
-200
| -13% | -$55.1K | 0.07% | 128 |
|
|
2013
Q3 | $490K | Sell |
1,565
-50
| -3% | -$15.7K | 0.1% | 127 |
|
|
2013
Q2 | $363K | Buy |
+1,615
| New | +$363K | 0.08% | 134 |
|